Table 1.

Post-acute COVID-19 symptoms of previously hospitalized patients at early and late time points after the initial illness.

	Early Visits	Late Visits	p-Value
Asymptomatic	25.93%	43.51%	0.1
Dyspnea	59.26%	40.91%	0.09
Dyspnea with m-MRC > 1	25%	15.97%	0.4
Cough	11.54%	8.44%	0.7
Fatigue	42.31%	23.87%	0.06
Muscular weakness	26.92%	13.55%	0.1
Myalgia/arthralgia	11.54%	5.81%	0.4
Weight loss > 4 kg	15.38%	9.68%	0.5
Dizziness/vertigo	7.69%	6.45%	0.7
Tremor	3.85%	1.95%	0.6
Numbness	0%	1.3%	0.9
Headache	7.69%	3.87%	0.3
Fever	0%	0.65%	0.9
Sweating	7.69%	5.84%	0.7
Gastrointestinal symptoms	0%	2.58%	0.9
Hairloss	11.54%	10.32%	0.7
Rash	0%	2.58%	0.9
Anosmia/ageusia	7.69%	1.3%	0.1
Palpitation	7.69%	5.16%	0.6
Psychological symptoms	23.08%	19.48%	0.4
Other	0%	4.52%	0.6

Symptoms of 122 patients during 4–84 weeks after the onset of acute disease (total 181 visits). Early follow-up visits are considered those that occurred within 89 days after acute COVID-19 onset (27 visits/27 patients) and late visits are considered those that occurred 90 days or more after the initial illness (154 visits/95 patients). Percentages correspond to symptoms reported by a patient during a visit. m-MRC: modified Medical Research Council dyspnea scale, EQ-VAS: visual analog scale of EQ-5D-5Lscore,EQ-5D-5L: European quality of life self-assessed questionnaire.